AI assistant
Sending…
IO Biotech, Inc. — Director's Dealing 2023
Jul 19, 2023
34883_dirs_2023-07-19_e866de2e-97f7-4c1f-ab64-d59260a24956.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2023-07-15
Reporting Person: Ahmad Qasim Iftikhar (N/A)
More from IO Biotech, Inc.
Board/Management Information
2026
Mar 31
Delisting Announcement
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 6
Regulatory Filings
2026
Jan 30
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2026
Jan 21
Delisting Announcement
2025
Dec 19
Board/Management Information
2025
Nov 21
Investor Presentation
2025
Nov 18